l carnitine and heart health Role of L-carnitine in Cardiovascular Health: Literature Review Carnitine Synergy™ | Superior Supplement
Description
Investors typically like hard endpoints for Phase 3 trials, like ESRD or death, but I believe that Pyridorin, if successful in providing at least a 28% reduction in SCr levels after 12 months, will be well received by nephrologists or endocrinologist when it comes time to sell the drug
1980 Feb;212(2):240245
This part is detailed in Interactions between ferroptosis and other forms of cell death in myocardial I/R injury
These are not included in the initial price quote but can increase long-term costs
